Trial reportObesity surgery2025
An Investigation into the Association Between Intravenous Crystalloid Administration and Perioperative Nausea and Vomiting in Morbidly Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy.
Trial report in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- The Effect of Intravenous Dextrose Administration on Postoperative Nausea and Vomiting: Systematic Review and Meta-Analysis with Trial Sequential Analysis.Medicina (Kaunas, Lithuania) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLaparoscopic sleeve gastrectomy (LSG) is among the most commonly preferred surgical methods for the treatment of morbid obesity. Postoperative nausea and vomiting (PONV) is a significant complication that adversely affects patient comfort and recovery. This study aims to evaluate the effects of intravenous sodium chloride and dextrose solutions on PONV in patients undergoing LSG. MATERIALS AND
methodsIn this prospective randomized controlled study, 201 patients who underwent LSG were randomly assigned to two groups. Based on intravenous (IV) fluid management, patients received either 0.9% sodium chloride + 5% dextrose (Group 1) or 0.9% sodium chloride alone (Group 2). The incidence of PONV, antiemetic and analgesic consumption, and time to first mobilization were recorded at 0, 15, and 30 min, and at 6 and 24 h postoperatively.
resultsGroup 1 demonstrated a significantly lower incidence of nausea upon admission to the post-anesthesia care unit (PACU) and at the 15th postoperative minute compared to Group 2. However, at 24 h postoperatively, Group 1 exhibited higher rates of nausea and vomiting. Additionally, Group 1 required increased opioid and antiemetic administration, experienced longer times to initial mobilization, and had prolonged discharge durations relative to Group 2.
conclusionThis study suggests that intravenous fluids containing dextrose may reduce early postoperative PONV but are associated with increased nausea and vomiting in the later postoperative period, leading to greater analgesic and antiemetic requirements. Therefore, avoiding dextrose- containing IV fluids in morbidly obese patients scheduled for surgery may help reduce the incidence of postoperative nausea and vomiting.
Indexed as
Identifiers
40730920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.